Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1CD34 + cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation ( EBMT )2020 · 39 citations
2. 2Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation2021 · 13 citations
3. 3HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide2021 · 123 citations
4. 4Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications–A single center experience from India2021 · 16 citations
5. 5The 2016 APBMT Activity Survey Report: Trends in haploidentical and cord blood transplantation in the Asia-Pacific region2020 · 13 citations